PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-26.90%
Revenue decline while VET shows 12.83% growth. Joel Greenblatt would examine competitive position erosion.
-6.19%
Cost reduction while VET shows 9.84% growth. Joel Greenblatt would examine competitive advantage.
-35.05%
Gross profit decline while VET shows 13.72% growth. Joel Greenblatt would examine competitive position.
-11.15%
Margin decline while VET shows 0.78% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-43.88%
Other expenses reduction while VET shows 9.58% growth. Joel Greenblatt would examine efficiency.
-40.07%
Operating expenses reduction while VET shows 4.86% growth. Joel Greenblatt would examine advantage.
-27.46%
Total costs reduction while VET shows 6.82% growth. Joel Greenblatt would examine advantage.
0.82%
Interest expense growth while VET reduces costs. John Neff would investigate differences.
-33.37%
D&A reduction while VET shows 16.88% growth. Joel Greenblatt would examine efficiency.
77.15%
EBITDA growth exceeding 1.5x VET's 19.58%. David Dodd would verify competitive advantages.
-4.32%
EBITDA margin decline while VET shows 5.98% growth. Joel Greenblatt would examine position.
507.34%
Operating income growth exceeding 1.5x VET's 21.09%. David Dodd would verify competitive advantages.
657.23%
Operating margin growth exceeding 1.5x VET's 7.31%. David Dodd would verify competitive advantages.
93.91%
Other expenses growth above 1.5x VET's 59.66%. Michael Burry would check for concerning trends.
200.95%
Pre-tax income growth below 50% of VET's 1391.80%. Michael Burry would check for structural issues.
238.10%
Pre-tax margin growth below 50% of VET's 1222.12%. Michael Burry would check for structural issues.
336.00%
Tax expense growth while VET reduces burden. John Neff would investigate differences.
104.88%
Net income growth below 50% of VET's 315.24%. Michael Burry would check for structural issues.
106.67%
Net margin growth below 50% of VET's 290.75%. Michael Burry would check for structural issues.
105.99%
EPS growth below 50% of VET's 316.13%. Michael Burry would check for structural issues.
105.99%
Diluted EPS growth below 50% of VET's 312.90%. Michael Burry would check for structural issues.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.